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Key Role of Toll-Like Receptor 2 in the Inflammatory Response and
Major Histocompatibility Complex Class II Downregulation in
Brucella abortus-Infected Alveolar Macrophages
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Guillermo H. Giambartolomei,c Sergio C. Oliveira,b Pablo C. Baldia
Instituto de Estudios de la Inmunidad Humoral (CONICET/UBA), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentinaa; Department
of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazilb; Instituto de Inmunología, Genética y
Metabolismo (CONICET/UBA), Hospital de Clínicas “José de San Martín,” Buenos Aires, Argentinac
Alveolar macrophages (AM) seem to constitute the main cellular target of inhaled brucellae. Here, we show that Brucella abortus
invades and replicates in murine AMwithout inducing cytotoxicity. B. abortus infection induced a statistically significant in-
crease of tumor necrosis factor alpha (TNF-), CXCL1 or keratinocyte chemoattractant (KC), interleukin-1 (IL-1), IL-6, and
IL-12 in AM from C57BL/6 mice and BALB/c mice, but these responses were generally weaker and/or delayed compared to those
elicited in peritoneal macrophages. Studies using knockout mice for TLR2, TLR4, and TLR9 revealed that TNF- and KC re-
sponses were mediated by TLR2 recognition. Brucella infection reduced in a multiplicity of infection-dependent manner the ex-
pression of major histocompatibility complex class II (MHC-II) molecules induced by gamma interferon (IFN-) in AM. The
same phenomenon was induced by incubation with heat-killed B. abortus (HKBA) or the lipidated form of the 19-kDa outer
membrane protein of Brucella (L-Omp19), and it was shown to be mediated by TLR2 recognition. In contrast, no significant
downregulation of MHC-II was induced by either unlipidated Omp19 or Brucella LPS. In a functional assay, treatment of AM
with either L-Omp19 or HKBA reduced theMHC-II-restricted presentation of OVA peptides to specific T cells. One week after
intratracheal infection, viable B. abortuswas detected in AM from both wild-type and TLR2 KOmice, but CFU counts were
higher in the latter. These results suggest that B. abortus survives in AM after inhalatory infection in spite of a certain degree of
immune control exerted by the TLR2-mediated inflammatory response. Both the modest nature of the latter and the modulation
of MHC-II expression by the bacteriummay contribute to such survival.
Brucellosis is zoonotic disease caused by Brucella species, whichis distributed worldwide and affects over 500,000 people an-
nually (1) and for which there is no approved efficacious human
vaccine available. Brucella melitensis, B. suis, and B. abortus are the
most pathogenic species for humans and are responsible for the
vastmajority of human cases (2). The infection can be transmitted
to humans by several ways, among which inhalation of infected
aerosols is one of the most frequent. The easy aerosolization and
airborne transmission of Brucella species has contributed to their
consideration as potential biological weapons (1) and their classi-
fication by the CDC andNIAID as category B bioterrorism agents.
Outbreaks of human brucellosis due to airborne transmission
have been reported in different settings, including abattoirs, vac-
cine production laboratories, and rural areas (3–5).Notably, aero-
sols have been implicated in most cases of laboratory-acquired
brucellosis, which is considered the commonest laboratory-ac-
quired infection (6).
Lung epithelial cells and alveolar macrophages (AM) are the
first cells to be contacted by inhaled microorganisms. AM consti-
tute the first line of pulmonary defense and are capable of initiat-
ing a local immune response to pathogens, maintaining the func-
tional integrity of pulmonary epithelium. Such immune response
relies to a great extent on the recognition of foreign antigens by
toll-like receptors (TLRs), which detect different pathogen-asso-
ciated molecular patterns (PAMPs), such as lipopolysaccharide
(LPS), peptidoglycan, lipoproteins, flagellin, CpG DNA motifs,
double-stranded RNA, etc., and trigger the activation of MyD88-
and TRIF-dependent signaling pathways that lead to a wide range
of cellular responses, including the secretion of proinflammatory
cytokines and chemokines and type I interferons, which contrib-
ute to the protective response to microbial pathogens (7). Previ-
ous studies have shown that TLR2, TLR4, and TLR9 are involved
in the recognition of Brucella by macrophages and dendritic cells
(8), but the importance of TLRs in the recognition of Brucella by
AM has not been characterized.
The interaction of Brucella with the pulmonary cells has
scarcely been studied. We have previously shown that Brucella
species can infect and replicate within human lung epithelial cells
and can induce these cells to produce the monocyte chemoattrac-
tant MCP-1 (9, 10). More recently, a study performed in mice
after intranasal inoculation of B. abortus revealed that AM consti-
tute the main cellular target of these inhaled bacteria. Moreover,
confocalmicroscopy studies indicated that the number of bacteria
per AM increased between days 2 and 5 postinfection (p.i.) (11).
Notably, in another study of mice infected with aerosolized B.
abortus, lung CFU counts increased steadily until week 4 p.i. and
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remained high at least until week 8 p.i. (12), suggesting that B.
abortus can replicate and persist within the murine lung. It can be
speculated that this long-term survival ofBrucella in the lung takes
place, at least in part, in AM.
The above speculation is also supported by the fact that several
studies have shown that Brucella can survive and replicate inside
human and murine macrophagic cells (13, 14). Key determinants
of such survival are the ability of the bacterium to avoid the fusion
of the Brucella-containing vacuole with lysosomes (15) and sev-
eral physiologic adaptations of the brucellae to their intracellular
niche (16). In addition, to avoid the T cell receptor (TCR)-medi-
ated recognition of infected monocytes/macrophages and an
eventual T cell-mediated activation of such cells, the bacterium
downmodulates the expression of MHC-II molecules on the cel-
lular surface of these phagocytes (17).
To the best of our knowledge, all of the studies regarding Bru-
cella invasion, replication, and immune evasion in monocytic/
macrophagic cells have been performed using cell lines, peripheral
blood monocytes, or murine peritoneal or bone marrow-derived
macrophages. No studies have been performed using isolatedAM.
This lack of knowledge is not trivial, since several studies have
shown that AM differ from other monocytic/macrophagic popu-
lations in several ways, including the cytokine response to infec-
tion or to stimulation with microbial antigens (18–23), the sus-
ceptibility to infection or the intracellular replication kinetics for
certain pathogens (22, 23), the signaling pathways or innate im-
munity receptors involved in responses to antigenic stimuli (24,
25), and several other aspects (26). Notably, a recent study showed
that AM can constitutively carry pathogens from the lung to the
draining lymph nodes even before dendritic cells (27). Therefore,
the main goals of the present study were to evaluate the time
course ofBrucella survival and replication inmurine AM, to assess
the cytokine response of these cells to infection, and to determine
whether Brucella can also downregulate MHC-II expression in
AM as a strategy to avoid or delay specific adaptive immune re-
sponses. The role of TLRs in the Brucella-mediated effects under
study was also evaluated.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The smooth strain Brucella
abortus 2308 was grown in tryptic soy broth at 37°C with agitation. Bac-
teria were washed twice with sterile phosphate-buffered saline (PBS), and
inocula were prepared in sterile PBS on the basis of the optical density
(OD) readings, but the actual concentration was later checked by plating
on agar. All live Brucellamanipulations were performed in biosafety level
3 facilities.When indicated,Brucella organismswerewashed five times for
10 min each in sterile PBS, heat killed at 70°C for 20 min, aliquoted, and
stored at70°C until they were used. The absence of B. abortus viability
after heat killing was verified by the absence of bacterial growth on tryp-
tose soy agar (TSA).
Reagents. B. abortus lipidated outer membrane protein 19 (L-
Omp19) and unlipidated Omp19 (U-Omp19) were obtained as de-
scribed previously (28). Both recombinant proteins contained less
than 0.25 endotoxin U/g of protein as assessed by Limulus amebocyte
lysates (Associates of Cape Cod). Protein concentration was determined
by the bicinchoninic acid method (Pierce, Rockford, IL) using bovine
serumalbumin (BSA) as the standard.B. abortus 2308 LPS andEscherichia
coli O111 strain K58H2 LPS were provided by I. Moriyón (University of
Navarra, Pamplona, Spain). The purity and characteristics of these prep-
arations have been described elsewhere (29). The synthetic bacterial lipo-
hexapeptide Pam3CysSerLys4 (Pam3Cys) was obtained from InvivoGen
(San Diego, CA).
Mice. Specific-pathogen-free, female BALB/c mice were purchased
from University of La Plata, La Plata, Argentina, and used at 8 weeks of
age. C57BL/6mice andTLR2, TLR4, TLR9, andMAL/TIRAP gene knock-
out (KO) mice bred on a C57BL/6 background were provided by Federal
University of Minas Gerais (UFMG), Brazil. Animals were housed in
groups of 5 animals under controlled temperature (22°C  2°C) and
artificial light under a 12-h cycle period. KOmice were kept under specif-
ic-pathogen-free conditions in positive-pressure cabinets and provided
with sterile food and water ad libitum. All animal procedures were per-
formed according to the rules and standards for the use of laboratory
animals of the National Institutes of Health. Animal experiments were
approved by the Ethical Committee of the IDEHU Institute and the Insti-
tutional Animal Care and Use Committee of the UFMG.
Murine alveolar macrophages. Murine alveolar macrophages were
isolated as previously described, with some modifications (30). Briefly,
mice were euthanized by an intraperitoneal injection of a lethal dose of
ketamine and xylazine, their tracheas were cannulated, and the airways
were perfused several times with 0.7 ml of sterile cold PBS containing 1
mM EDTA to provide 4 ml of bronchoalveolar lavage (BAL) fluid. BAL
fluid samples were centrifuged at 400 g for 10 min at 4°C, and the cells
present in the pellet were resuspended in RPMI 1640 medium supple-
mented with 10% heat-inactivated fetal bovine serum (FBS) (Gibco-BRL
Life Technologies, Grand Island, NY), 100 U of penicillin per ml, and 50
g of streptomycin per ml. Cell viability was routinely greater than 95%,
as determined by trypan blue exclusion. Cells were dispensed in culture
plates of 48 wells at 2  105 or 5  105 cells/well and incubated in a 5%
CO2 humidified atmosphere for 2 h at 37°C for adhesion before stimula-
tion. After incubation, culture supernatants were discarded and cells were
washed several times with culture medium to remove nonadherent cells.
The identity of adherent cells as alveolar macrophages was confirmed by
flow cytometry using anti-CD11c and anti-F4/80 antibodies as described
below.
Murine peritoneal macrophages. Peritoneal macrophages were ex-
tracted from BALB/c and C57BL/6 mice by peritoneal washing with ice-
cold PBS-EDTA 1 mM and were enriched by plastic adherence in 48-well
plates incubated for 1 h at 37°C in a 5% CO2 atmosphere. Cells (5 10
5
cells/well) were washed with fresh RPMI and then cultured overnight in
RPMI, 2mMglutamine, 100 U/ml of penicillin, and 50g/ml streptomy-
cin supplemented with 10% FBS before infection.
Cellular infections. Infections were performed at multiplicities of in-
fection (MOI) of 100 bacteria/cell in culture medium containing no anti-
biotics. After dispensing the bacterial suspension, the culture plates were
centrifuged (10 min at 300 g at room temperature) and then incubated
for 2 h at 37°C under 5%CO2 atmosphere. At the end of incubation (time
zero p.i.), each well was washed three times with sterile PBS. For quanti-
fication of intracellular bacteria, the infected monolayers were incubated
in the presence of 100g/ml of gentamicin (Sigma, USA) and 50g/ml of
streptomycin (Sigma, USA) to kill extracellular bacteria. At different
times after antibiotic addition (2, 24, or 48 h), culture supernatants were
harvested for cytokine determinations, whereas cells were washed with
sterile PBS and lysedwith 0.2%TritonX-100. Serial dilutions of the lysates
were plated on TSA to enumerate CFU.
Evaluation of cytotoxicity. The reduction of the barrier function of
the cell membrane is a marker of cytotoxicity. To analyze the effect of
infection on cell membrane permeability, the release of lactate dehydro-
genase (LDH) from infected macrophages was determined. Cells were
infectedwithB. abortus 2308 at anMOI of 100 as described above. Culture
supernatants were harvested at 24 and 48 h p.i., and LDH levels were
measured using the CytoTox 96 nonradioactive cytotoxicity assay (Pro-
mega, USA) according to the instructions of themanufacturer. Other AM
cultured in parallel were left uninfected to determine basal LDH release.
In order to determine the LDH value corresponding to the lysis of all the
cells (maximum lysis), other wells containing AMwere treated for 60min
at 37°C with the lysis buffer provided in the kit (freeze-thaw lysis was
employed in other experiments with similar results). Fifty microliters of
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each culture medium (infected or uninfected AM and maximum lysis
control) were collected and transferred to a 96-well plate. After mixing
each sample with 50 l of substrate mix, the plate was covered and incu-
bated for 30 min at room temperature protected from light. Finally, 50l
of stop solution was added and the OD at 490 nm of each well was mea-
sured in amicroplate reader. To account for the endogenous LDHactivity
of the fetal bovine serum, 50 l of fresh culture medium was processed
in the same way in parallel, and this background value was subtracted
from the readings of all other samples. The relative LDH release (indicator
of the percentage of cytotoxicity) was calculated as the ratio between the
OD value measured for infected or uninfected cells and that correspond-
ing to maximum lysis.
Measurement of cytokine concentrations.Murine CXCL1 or kerati-
nocyte chemoattractant (KC), interleukin-6 (IL-6), IL-1, monocyte che-
moattractant protein 1 (MCP-1), IL-12 p40/p70, and TNF- were mea-
sured in culture supernatants of Brucella-infected AM by sandwich
enzyme-linked immunosorbent assay (ELISA) (all from BD Biosciences,
San Diego, CA, except for KC, which was from R&D, Minneapolis, MN)
using paired cytokine-specific monoclonal antibody according to the
manufacturer’s instructions.
Effect of infection orBrucella antigens onMHC-II expression.Alve-
olar macrophages from wild-type (wt) and TLR KO mice (0.5  106
cells/well) were incubated with 150 U/ml of recombinant murine IFN-
(Thermo Fisher Scientific, USA) in the absence or presence of heat-killed
B. abortus (HKBA; 107 to 109 CFU/ml), L-Omp19, U-Omp19, Pam3Cys,
CpG, E. coli LPS, or Mycobacterium tuberculosis lysate for 48 h at the
indicated concentrations. At the end of culture, cells were washed three
times with sterile PBS and resuspended in Fc block (at a concentration of
2 g/ml in 0.1% BSA in PBS) for 15 min on ice. The cells then were
incubated for 30min on icewith a phycoerythrin-labeled antibody against
murine MHC-II (including I-Ab and I-Ad molecules; clone M5/114.15.2;
eBioscience), a fluorescein isothiocyanate-labeled anti-mouse CD11c an-
tibody (clone HL3; BD Bioscience), an allophycocyanin-labeled anti-
mouse F4/80 antibody (clone CI:A3-1; Serotec), or an isotype-matched
control antibody (BD Bioscience). The cells were then washed in BSA in
0.1% PBS and fixed with 1% paraformaldehyde in PBS (pH 7.4). Samples
were stored in the dark at 4°C for subsequent analysis with a FACScanflow
cytometer (Becton, Dickinson, Franklin Lakes, NJ) using CellQuest soft-
ware (Becton, Dickinson). A total of 10,000 to 20,000 ungated events were
collected. The results were expressed as mean fluorescence intensities
(MFI; arithmetic means standard errors of the means [SEM]).
In infection experiments, 0.5  106 cells/ml were infected with B.
abortus at MOIs of 10, 50, or 100 in the presence of IFN- for 2 h in
standard medium containing no antibiotics. The cells then were exten-
sively washed to remove noninternalized bacteria, and the infected cells
were maintained in the presence of IFN- for an additional 48 h. After
this, flow cytometry was conducted as indicated above.
Antigen presentation assay. Alveolar macrophages were harvested as
described above, plated onto 96-well flat-bottom plates (1.5  105 cells/
well) in completemedium, and allowed to adhere overnight at 37°C. Cells
were washed five times and treated with complete medium with or with-
out L-Omp19 orHKBA in the presence of IFN-. After 48 h of incubation,
alveolar macrophages were washed extensively with warm culture me-
dium to remove residual IFN- and antigens. Cells then were incubated
with 50 to 5,000 g/ml of ovalbumin (OVA; Sigma) for 6 h, followed by
incubation with BO97.10 T hybridoma cells (105 cells/well) specific for
the OVA323-339 peptide presented on I-Ab (31). Culture supernatants
were removed after 24 h and stored at70°C until they were assayed for
IL-2 levels by commercial ELISA (BD Biosciences).
Intratracheal infection and lung processing.Mice were anesthetized
by intraperitoneal injection of ketamine and xylazine andwere inoculated
intratracheally with 100 l of B. abortus suspension (1 106 CFU/ml) by
following the procedure described by Revelli et al. (32), with minor mod-
ifications. At 7 days postinfection, mice were euthanized by intraperito-
neal overdose of ketamine/xylazine and BAL samples were obtained as
described above. Cells from BAL fluid were resuspended in RPMI-10%
FBS without antibiotics, and aliquots were taken for cell counting. Cell
suspensions were adjusted to 5  105 cells/ml, and 1 ml per well was
dispensed in 24-wells plates. Cells were incubated for 2 h at 37°C in a 5%
CO2 atmosphere and were washed 3 times with sterile PBS to remove
nonadherent cells. Adherent cells were lysed and plated for CFU determi-
nations as described for in vitro infections. After the BAL procedure, lungs
were homogenized in sterile PBS using a tissue grinder, and different
dilutions of the resulting cell suspensions were plated on agar for CFU
counting.
Statistical analysis. Data were analyzed using analysis of variance
(ANOVA). Comparisons between groups of data were performed with
the Tukey’s posttest, and those against a control group were performed
with Dunnett’s test. All of the statistical analyses were performed using
GraphPad software (San Diego, USA).
RESULTS
Brucella abortus invades and replicates within murine alveolar
macrophages. Experiments were carried out to determine whether
B. abortus invades alveolar macrophages (AM) and establishes a
replication niche within these cells. Murine AM were infected for
2 h at anMOIof 100 bacteria/cell, extracellular bacteriawere killed
by treatment with antibiotics, and intracellular CFU were deter-
mined at different times postinfection (p.i.) by plating cellular
lysates in agar. As shown in Fig. 1 (upper and middle), B. abortus
was able to invade and replicate within AM from both C57BL/6
and BALB/c mice, as CFU counts of intracellular bacteria in-
creased steadily during the whole follow-up period. The detection
of released lactate dehydrogenase (LDH) is widely used as a mea-
sure of cell damage or death for most cell types, including AM
(33). To evaluate a potential cytotoxic effect of Brucella infection
on AM, levels of LDH activity were measured in culture superna-
tants from B. abortus-infected AM at 24 and 48 h p.i. At both time
points no significant difference in LDH activity was detected be-
tween supernatants from Brucella-infected cells and those from
uninfected AM from both BALB/c mice (Fig. 1, lower) and
C57BL/6 mice (not shown). Taken together, these results indicate
that virulent B. abortus can survive and replicate inside alveolar
macrophages, and that the increasing load of intracellular bacteria
does not result in cytotoxic effects on these cells.
Proinflammatory response of AM to B. abortus infection.
The levels of several proinflammatory cytokines, including
TNF-, IL-1-, KC, IL-6, MCP-1, and IL-12, were measured at
different p.i. times in culture supernatants from B. abortus-in-
fectedAM.As shown in Fig. 2, at 24 h p.i. cytokineswere either not
detected or were present at very low levels in supernatants from
infected AM from C57BL/6 mice. Except for MCP-1, which was
not detected at any p.i. time, cytokine levels increased at 48 h p.i.
compared to those at 24 h p.i. Nevertheless, levels were rather low
for IL-6 and IL-12, whereas the highest levels corresponded to
TNF-, IL-1, and KC.
A similar profile of cytokine response was observed for AM
from BALB/c mice (Fig. 3). Again, all of the cytokines were at low
levels or were absent at 24 h p.i., and all of them (except MCP-1,
which was never detected) increased at 48 h p.i., with the highest
increases for TNF- and KC and, to a lesser extent, IL-1. As the
cytokine response of AM to bacterial antigens usually differs from
that of macrophages from other localizations, generally resulting
in a milder proinflammatory profile (22, 23), cytokine levels were
also measured in culture supernatants from B. abortus-infected
peritoneal macrophages (PM) from BALB/c mice and compared
Ferrero et al.
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to those obtained for AM from the same animals. As shown in
Fig. 3, cytokine responses were generally weaker and/or delayed
compared to those elicited in PM.While, as mentioned, cytokines
were either absent or low at 24 h p.i. in AM, all were already
produced by infected PM at this time point. For all of the cyto-
kines, levels detected at 24 h p.i. were significantly higher for PM
than for AM (P	 0.001 in all cases). MCP-1 was not detected in
culture supernatants from B. abortus-infected AM at any time
point but was detected in Brucella-infected PM at both p.i. times.
Overall, these results indicate that murine AM respond to B.
abortus infectionwith a delayed and restricted panel of proinflam-
matory mediators (mainly represented by TNF- and KC) com-
pared to murine PM.
The proinflammatory response of AM to Brucella is mainly
TLR2mediated. To determine whether Toll-like receptors (TLR)
are involved in the induction of cytokine responses, infections
were performed in parallel in AM from C57BL/6 mice (wt) and
frommice of the same background genetically deficient for TLR2,
TLR4, or TLR9. We chose to evaluate these receptors since they
were demonstrated to be important for cytokine production in
response to Brucella in PM and dendritic cells (8). Since KC and
TNF- were markedly induced by infection in AM from wt mice,
these cytokines weremeasured in experiments with AM fromTLR
KO mice. As shown in Fig. 4A, TNF- and KC were greatly re-
duced in supernatants of AM from TLR2 KO mice compared to
those from wt mice (92% and 97% reduction, respectively). In
contrast, the production of both cytokines was much less reduced
in cells from TLR4 KO mice (significant reduction only for
TNF-) and TLR9 KO mice (29% and 23% reduction, both sta-
tistically significant). TNF- production in response to infection
was significantly lower in AM from TLR2 KO mice than in those
fromwt, TLR4 KO, or TLR9 KOmice (P	 0.001 in all cases), and
the same was true for KC production (P 	 0.001 in all cases).
These results suggest that TNF- and KC production by AM in
response to B. abortus infection depends mainly on TLR2 recog-
nition, with significantly smaller contributions of TLR4 and
TLR9. In agreement with the results obtained with TLR2 and
TLR4 KO mice, the TNF- and KC responses of AM from mice
deficient in the adaptor protein MAL/TIRAP were also greatly
reduced (95% and 98% reduction, respectively) compared to wt
mice.
To rule out that differences in TNF- and KC production be-
tween AM from wt and TLR2 KO mice were due to differences
between these cells in the rate of Brucella infection or replication,
CFU counts in AM lysates were determined at 2 and 24 h p.i. As
shown in Fig. 4B, no significant differences in B. abortus CFU
counts were found between AM from wt and TLR2 KO mice at
both p.i. times.
Both live and heat-killed Brucella organisms downregulate
MHC-II expression in AM. As mentioned, previous studies have
shown thatB. abortus can replicate and survive for several weeks in
lungs of mice infected through the nasal route (12), suggesting
that the bacterium displaysmechanisms of immune evasion at the
pulmonary level. Since it has been shown that mycobacteria can
downregulate the expression of MHC-II molecules in macro-
phages (30, 34), we decided to test whether this evasion mecha-
nism also operates in Brucella infections. AM from C57BL/6 and
BALB/c mice were left uninfected or were infected with B. abortus
at different multiplicities of infection for 2 h in the presence of
IFN- (as an inducer of MHC-II expression), washed extensively,
and maintained in the presence of IFN- for an additional 48 h.
After this, the expression of MHC-II (I-Ad) was evaluated by flow
cytometry. As shown in Fig. 5, the expression of MHC-II was
significantly reduced in cells that had been incubated with live B.
abortus during the first 2 h of IFN- stimulation compared to cells
incubatedwith IFN- alone. For AM frombothmouse strains, the
downregulating effect of B. abortus infection wasMOI dependent,
with mean fluorescence intensity (MFI) reductions of 25%, 62%,
and 70% for MOIs of 10, 50, and 100, respectively, in AM from
C57BL/6mice and 25%, 35%, and 44% in AM fromBALB/cmice.
To determine whether this downregulation is mediated by struc-
tural components of the bacterium, AM from BALB/c mice were
stimulated with IFN- in the absence or presence of heat-killed B.
FIG 1 Invasion and intracellular replication of B. abortus in murine alveolar
macrophages (AM). AM (2  105 cells/well) from C57BL/6 mice (upper
panel) or BALB/c mice (middle panel) were infected at an MOI of 100 for 2 h,
and intracellular CFU were measured at different times p.i. Results are ex-
pressed as means SEM of values measured in triplicate in each experiment.
Data are representative of an experiment from three performed with similar
results. (Lower) Effect of Brucella infection on the cell membrane permeability
of AM from BALB/c mice. Cells were infected as described above, and culture
supernatants were collected at 24 and 48 h p.i. to measure LDH levels. Results
are expressed as the ratio between LDH levels found in infected or noninfected
(NI) cells and those found in a whole cellular lysate (100% lysis). B. ab., B.
abortus.
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abortus (HKBA) for 48 h, and the expression ofMHC-IImolecules
was evaluated as described above. As shown in Fig. 5 (lower), the
heat-killed bacterium also induced a significant MHC-II down-
regulation, suggesting that this effect was due to a structural com-
ponent of Brucella. The downregulating effect of HKBA was dose
dependent, withMFI reductions of 20%, 77%, and 91% forHKBA
doses of 107, 108, and 109 CFU/ml, respectively.
These results indicate that infection with B. abortus induces a
downregulation of MHC-II expression in AM, and that this phe-
nomenon is mediated by a structural component of the bacte-
rium.
Lipoproteins mediate the downregulation of MHC-II by
Brucella. Previous studies on MHC-II downregulation by M.
bovis have shown that such an effect may bemediated by a 19-kDa
lipoprotein of this bacterium (30). Interestingly, previous studies
from our group have shown that Brucella lipoproteins, and in
particular the lipidated form of a 19-kDa lipoprotein (L-Omp19),
may mediate important biological activities in human peripheral
monocytes, such as the induction of proinflammatory responses
and the downregulation of FcRI (CD64) andMHC-II expression
(17, 28, 35). Therefore, we decided to test whether L-Omp19 also
is involved in the downregulation of MHC-II molecules induced
by Brucella in AM. To do this, AM were incubated with murine
IFN- in the absence or presence of this lipoprotein. As shown in
Fig. 6, incubation with L-Omp19 induced a downregulation of
MHC-II compared to cells treated only with IFN-. The down-
regulating effect of L-Omp19 was dose dependent, with MFI re-
ductions of 44%, 79%, and 92% for L-Omp19 doses of 10, 100,
and 1000 ng/ml, respectively. The downregulating effect of
L-Omp19 onMHC-II expression depended on the lipidmoiety of
the lipoprotein, since its unlipidated version (U-Omp19) did not
decrease MHC-II expression even when used at high concentra-
tions (5,000 ng/ml). The requirement for lipidation was further
supported by the fact that Pam3Cys, a synthetic lipohexapeptide
that mimics the lipid moiety of lipoproteins, also downregulated
in a dose-dependent manner the expression of MHC-II induced
by IFN- (Fig. 6). These results suggest that L-Omp19 (and prob-
ably other Omps) is involved in the downregulating effect of B.
abortus on the IFN--inducedMHC-II expression inmurine AM.
Since LPS from some bacteria have been shown to diminish
MHC-II expression in peritonealmacrophages (36), the LPS from
B. abortuswas considered another candidate molecule potentially
FIG 2 Secretion of proinflammatory cytokines by AM from C57BL/6 mice in response to B. abortus infection. Alveolar macrophages were infected as described
for Fig. 1, and culture supernatants were harvested at 24 and 48 h tomeasure cytokines by sandwich ELISA. NI, noninfected cells. B. ab., B. abortus-infected cells.
LPS, cells stimulated with lipopolysaccharide from E. coli (100 ng/ml). Data represent means standard deviations (SD) from values measured in triplicate in
each experiment. The figure shows a representative experiment from two performed with similar results. Asterisks indicate significant differences between
infected and uninfected cells at each time point (*, P	 0.05; **, P	 0.01; ***, P	 0.001) (ANOVA followed by Dunnett’s posttest).
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involved in the inhibition of MHC-II expression in AM. Thus,
experiments were conducted to evaluate the contribution of B.
abortus LPS to such an effect. As shown in Fig. 6, B. abortus LPS
was unable to inhibit the expression of MHC-II molecules even
when used at high concentrations (5,000 ng/ml). In contrast, LPS
from E. coli inhibited in a dose-dependent manner the IFN--
induced MHC-II expression, attaining MFI reductions of 95.5%
and 88.2% at doses 10 and 50 times lower than those used for
Brucella LPS (1,000 and 100 ng/ml, respectively) (data not
shown).
Taken together, these results indicate that B. abortus lipopro-
teins, but not its LPS, contribute to the downmodulation of
MHC-II in murine AM induced by HKBA stimulation or B. abor-
tus infection.
MHC-IIdownregulationbyBrucella isTLR2mediated.Since
TLR2, TLR4, and TLR9 have been shown to be involved in im-
mune responses to Brucella infection and to Brucella antigens (8),
experiments were carried out to determine if one or more of these
receptors was involved in the downregulation of MHC-II expres-
sion induced byB. abortus antigens inmurine AM. To do this, AM
from wt C57BL/6 mice or from TLR2, TLR4, and TLR9 KO mice
of the C57BL/6 backgroundwere incubatedwithmurine IFN- in
the absence or presence ofHKBA, L-Omp19, or LPS fromB. abor-
tus. Pam3Cys, E. coli LPS, and CpG were included in parallel ex-
periments, since TLR2, TLR4, and TLR9 agonists have been
shown to downregulate MHC-II expression in murine peritoneal
macrophages (36, 37).
As shown in Fig. 7, the IFN--induced MHC-II expression on
AM from wt C57BL/6 mice was downregulated by coincubation
withHKBA and L-Omp19 but not by coincubationwith LPS from
B. abortus, in agreement with results obtained with AM from
BALB/c mice (Fig. 6). Results obtained with AM from TLR4 and
TLR9 KOmice were similar to those yielded by AM fromwtmice,
indicating that these receptors are not involved in the downregu-
lation of MHC-II expression by Brucella antigens. In contrast, the
downregulating effect of HKBA and L-Omp19 on MHC-II ex-
pression was abolished in AM obtained from TLR2 KO mice, in-
dicating that this receptor is involved in such an effect. The down-
regulating effect was also abolished in AM from MAL/
TIRAP KO mice, in agreement with the involvement of TLR2 in
MHC-II downregulation by Brucella antigens.
These results indicate that TLR2 recognition mediates the
downregulating effect of Brucella antigens onMHC-II expression
in murine AM.
Functional evidence of MHC-II downregulation. To exam-
ine whether MHC-II downregulation by Brucella has a func-
tional consequence on the ability of AM to present antigenic pep-
tides to specific T cells, AM from C57BL/6 mice were treated with
IFN- alone or with the addition of L-Omp19 or HKBA. After 48
h, these cells were incubated with different amounts of ovalbumin
and with a T cell hybridoma specific for an ovalbumin peptide
presented in the context of I-Ab. As a measure of T cell activation,
the levels of IL-2 were determined in culture supernatants at 24 h
of coculture. As shown in Fig. 8, IL-2 levels were significantly
lower in wells in which AMhad been pretreated with L-Omp19 or
HKBA than in nonpretreated cells. These results suggest that the
reduction of MHC-II expression on AM induced by Brucella af-
fects the ability of these cells to present MHC-II-restricted anti-
gens to specific T cells, reducing the activation of the latter.
Impact of TLR2 absence on Brucella survival in AM. Our in
FIG 3 Secretion of proinflammatory cytokines by AM and peritoneal macro-
phages (PM) from BALB/c mice in response to B. abortus infection. Alveolar
macrophages were infected as described for Fig. 1, and culture supernatants
were harvested at 24 and 48 h to measure cytokines by sandwich ELISA. NI,
noninfected cells. B. ab., B. abortus-infected cells. LPS, cells stimulated with
lipopolysaccharide from E. coli (100 ng/ml). Data represent means SD from
values measured in triplicate in each experiment. The figure shows a represen-
tative experiment from two performed with similar results. Asterisks indicate
significant differences between infected and uninfected cells at each time point
(*, P 	 0.05; **, P 	 0.01; ***, P 	 0.001) (ANOVA followed by Dunnett’s
posttest).
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vitro experiments revealed two TLR2-mediated phenomena that
may have opposite effects on bacterial clearance: the production
of proinflammatory cytokines (which may favor clearance) and
the downregulation ofMHC-II (whichmay favor bacterial persis-
tence). The net effect of TLR2 recognition on Brucella survival in
AM probably results from a balance between these two TLR2-
mediated phenomena. To test the in vivo effect of TLR2 absence
on Brucella survival within AM, wt and TLR2 KO C57BL/6 mice
were infected with B. abortus through the intratracheal route. AM
were obtained at 1week p.i., lysed, andplated on agar to determine
intracellular CFU counts. After bronchoalveolar lavage to obtain
AM, lungs were processed and homogenates were also plated on
agar. As shown in Fig. 9, viable bacteria were recovered from AM
and lung homogenates from bothmouse strains. However, bacte-
rial counts were significantly higher in AM and lung homogenates
from TLR2 KO mice than in those from wt mice. These results
suggest that although the TLR2-mediated inflammatory response
is important for controlling B. abortus infection in AM, the bac-
terium may still survive in these cells for at least 1 week after
inhalatory infection.
DISCUSSION
Airborne transmission is an important route for the acquisition of
Brucella species infections by humans (4, 5) and may be also in-
volved in animal cases. In spite of this, the interaction of brucellae
with cells of the respiratory system has been scarcely documented,
and in particular, the immunological aspects of such interaction
have only recently begun to be studied (9, 11).
Alveolarmacrophages (AM) and alveolar epithelial cells are the
first cells contacted by inhaled bacteria immediately after reaching
the lungs through infected aerosols. In the case of B. abortus, a
recent study in mice has shown by confocal microscopy that AM
constitute themain cellular target of these bacteria after intranasal
infection (11).While an extensive body of literature has examined
many aspects of the interaction between brucellae and different
types of human or animal monocytic/macrophagic cells, there are
no reports on the interaction between these bacteria and AM.
Taking into account that AM differ from other monocytic/mac-
rophagic populations in several ways, including cytokine response
to infection or innate immunity receptors involved (19–21, 24,
25), we decided to characterize these aspects in the case of the
interaction between brucellae and murine AM. In addition, since
Mycobacterium tuberculosis has been shown to downregulate
MHC-II expression in AM (37), we wondered whether a similar
phenomenon occurs in Brucella-infected AM.
Our results show that B. abortus invades and replicates in mu-
rine AM. The ability of brucellae to replicate inside AM is in line
with the findings of Archambaud et al. (11), who observed the
same phenomenon by confocal microscopy, and is also in line
with similar findings in several types of monocytic/macrophagic
cells (13, 14). Notably, the infection did not induce cytotoxicity as
measured by LDH release, suggesting that the viability of AM is
not affected by B. abortus in spite of the marked increase in intra-
cellular bacterial load. These results suggest that AM constitute a
durable replicative niche for brucellae in the lung.
Previous studies have shown that mouse peritoneal macro-
phages andmacrophagic cell lines respond to Brucella infection or
stimulation with the production of the proinflammatory cyto-
kines TNF-, IL-1, and IL-6 and the Th1-inducing cytokine
IL-12 (38–43). In contrast, the cytokine response of AM to Bru-
FIG 4 (A) Cytokine secretion by AM fromC57BL/6mice in response toB. abor-
tus infection depends mainly on TLR2 recognition. Alveolar macrophages
from wild-type (WT) and TLR or MAL/TIRAP mutant mice were infected as
described for Fig. 1, and culture supernatants were harvested at 48 h to mea-
sure TNF- and KC by sandwich ELISA. NI, noninfected. Data represent
means SD from valuesmeasured in triplicate in each experiment. The figure
shows a representative experiment from two performed with similar results.
Asterisks indicate significant differences between mutant mice and WT mice
(*, P 	 0.05; **, P 	 0.01; ***, P 	 0.001; NS, nonsignificant) (ANOVA
followed by Tukey’s posttest). Bru, B. abortus. (B) TLR2 is not involved in
Brucella invasion to AM. AM from WT and TLR2 KO mice were infected as
described above, and cell lysates were obtained at 4 and 24 h p.i. to determine
intracellular CFU counts. Data represent means SD from values measured
in duplicate in each experiment. The figure shows a representative experiment
from two performed with similar results.
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cella has not been reported. In the present study, we found that
AM from both BALB/c and C57BL/6 mice respond to Brucella
infection with a marked increase in the secretion of TNF-, KC
(neutrophil chemoattractant), and IL-1 at 48 h p.i. but only low
levels of IL-12 and IL-6. In addition, these cells do not produce
MCP-1 in response toBrucella infection. Therefore, uponBrucella
recognition AM seem to elicit a relatively attenuated inflamma-
tory response with preserved KC and TNF- secretion. The sig-
nificant production of TNF- and KC by Brucella-infected AM
suggests that these cells contribute to the recruitment of neutro-
FIG 5 Brucella infection or stimulation with heat-killed bacteria (HKBA) downregulates IFN--induced MHC-II expression in murine AM. Alveolar macro-
phages from C57BL/6 (upper panels) or BALB/c mice (middle panels) were incubated for 2 h with IFN- in the presence or absence of different MOIs of live B.
abortus and then were maintained in the presence of IFN- for an additional 48 h. The expression of MHC-II molecules (I-Ad) was measured by flow cytometry
using a specific antibody. Similar experiments were performed with AM from BALB/c mice but replacing the infection with stimulation with HKBA (lower
panels). Panels on the right show mean fluorescence intensity (MFI) from values measured in duplicate in each experiment. The figure shows a representative
experiment from three performed with similar results. Asterisks indicate significant differences between untreated cells or cells stimulated with IFN- plus live
bacteria or HKBA compared to those stimulated with IFN- alone (*, P	 0.05; **, P	 0.01; ***, P	 0.001; ANOVA followed by Dunnett’s posttest).
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FIG 6 Downregulation of IFN--inducedMHC-II expression inmurine AM ismediated by Brucella lipoproteins. Cells were incubated for 2 h with IFN- in the
presence or absence of different doses of L-Omp19, U-Omp19, Pam3Cys, or Brucella LPS and were then maintained in the presence of IFN- for an additional
48 h. The expression ofMHC-IImolecules (I-Ad)wasmeasured by flow cytometry using a specific antibody. Panels on the right showmeanfluorescence intensity
(MFI) from values measured in duplicate in each experiment. The figure shows a representative experiment from three performed with similar results. Asterisks
indicate significant differences between untreated cells or cells stimulated with IFN- plus Brucella antigens or Pam3Cys compared to those stimulated with
IFN- alone (**, P	 0.01; ***, P	 0.001; ns, nonsignificant; ANOVA followed by Dunnett’s posttest).
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phils to the infection focus. A moderate amount of neutrophilic
inflammation has been reported in the few histological studies
performed in animal models of acute inhalational brucellosis
(44, 45).
The profile of cytokine response of murine AM to Brucella
infection differed from that found in PM.While infection elicited
a marked increase of TNF- in both AM and PM, the AM re-
sponse was delayed compared to that of PM. The significant in-
crease of TNF- levels in response to Brucella agrees with data
FIG 7 Brucella-induced downregulation of MHC-II depends on TLR2 andMAL/TIRAP signaling. AM fromwt C57BL/6 mice or from TLR2, TLR4, TLR9, and
MAL/TIRAP KOmice from a C57BL/6 background were incubated with murine IFN- in the absence or presence of HKBA, L-Omp19, or LPS from B. abortus
(LPS Br) for 48 h. LPS from E. coli, Pam3Cys, and CpGwere included as control agonists for TLR4, TLR2, and TLR9, respectively. The expression ofMHC-II was
assessed by flow cytometry. Results are expressed as mean fluorescence intensity (MFI) with their corresponding SEM values. Data are representative of an
experiment from three performed with similar results. *, P	 0.05; **, P	 0.01; ***, P	 0.001 versus IFN- alone (ANOVA followed by Tukey’s posttest).
FIG 8 MHC-II downregulation by Brucella antigens impairs the ability of AM
to stimulate OVA-specific T cells. AM from C57BL/6 mice were treated with
IFN- alone or with the addition of L-Omp19 or HKBA. After 48 h, these cells
were incubated with different amounts of OVA and with a T cell hybridoma
specific for an OVA peptide presented in the context of I-Ab (MHC-II). IL-2
levels weremeasured in the culture supernatants 24 h later. Data are presented
asmeans SD of IL-2 concentrations assayed in triplicate in each experiment.
The figure shows a representative experiment from three performed with sim-
ilar results. P	 0.05 (*) and P	 0.01 (**) versus IFN- (ANOVA followed by
Dunnett’s posttest).
FIG 9 TLR2 absence impacts the ability of AM to control B. abortus infection.
Wild-type C57BL/6 mice and TLR2 KO mice were infected intratracheally
withB. abortus andwere euthanized 1week later. Cells obtained by bronchoal-
veolar lavage were adjusted to 5  105/ml and were dispensed in wells of a
24-well plate. Adherent cells were lysed, and lysates were plated for CFU de-
termination. After bronchoalveolar lavage was performed, lungs were homog-
enized in sterile PBS and different dilutions of the resulting cell suspensions
were plated on agar for CFU counting. Data represent means  SD of CFU/
well (AM) or CFU/lungs determined in duplicate in one experiment from two
performed with similar results. Data for each type of sample were analyzed
using an unpaired t test.
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previously reported for murine PM and J774.A1 cells (39, 43).
Differences in the kinetics of AM and PM responses were even
moremarked for KC, which was produced at very high levels at 24
h p.i. by Brucella-infected PM but did not exhibit a significant
increase in AM at that time. Whereas IL-6 has been shown to be
induced by Brucella infection in PM and J774.A1 cells (41, 43) and
was also significantly induced in PM at 24 and 48 h p.i. in the
present study, this cytokine was not increased in Brucella-infected
AMat 24 h p.i. and exhibited only a small increase at 48 h p.i. IL-12
was secreted by B. abortus-infected PM, in agreement with previ-
ous studies (40), but its production by infected AM was compar-
atively low and delayed. The monocyte chemoattractant MCP-1
has been shown to be induced by Brucella infection in the murine
macrophagic cell line RAW 264.7 and microglia cells (46, 47). In
the present study, MCP-1 was produced early (24 h p.i.) by PM in
response to B. abortus infection but was not produced by infected
AM at any time point. Taken together, these results suggest that
AM produce a weaker and/or delayed cytokine response to B.
abortus compared to PM. This restricted response may be benefi-
cial for Brucella infection, since some of the affected cytokines are
known to be involved in the control of such infection. It is known
that TNF- is important for the influx of phagocytes to the site of
infection and for macrophage activation and is critically involved
in immune responses to intracellular pathogens. Previous studies
have shown that the spleen load of Brucella is increased in mice
treated with neutralizing antibodies against TNF- (48). Al-
though studies on localized effects of TNF-deficiency atmucosal
surfaces are lacking, it can be speculated that the comparatively
delayed TNF- production by AM in response toB. abortus favors
the bacterium. It is known that IL-12 promotes efficient immune
responses against intracellular pathogens not only by inducing a
Th1 profile but also by promoting the migration of dendritic cells
to draining lymph nodes (49). A central role for IL-12 in the con-
trol of B. abortus infection also has been demonstrated (42). Thus,
a reduced local production of IL-12 may contribute to the long-
term persistence of Brucella in the lung.
In the present study, IL-1 was among the cytokines induced
by Brucella infection in AM, although its production by these cells
was delayed compared to PM responses. While studies have
shown that the genetic deficiency of IL-1 does not alter the
splenic load of B. abortus in mice infected through the intraperi-
toneal route (50), the importance of this cytokine for the response
to inhaled Brucella has not been explored. AM seemed to be poor
producers of IL-1 upon LPS stimulation, since this was the only
cytokine not elicited by the dose of E. coli LPS used as a control in
cytokine assays (0.1 g/ml). In line with these findings, murine
AMhave been reported to respond to a 10-fold higher dose of LPS
than the one used here (1g/ml), with low levels of IL-1 (around
35 pg/ml) but high levels of KC (around 10 ng/ml) (51).
TLRs are involved in the inflammatory response of macro-
phages and other cell types to infection by different pathogens or
to stimulation with their antigens. In the case of Brucella, previous
studies have shown that TLR2 recognition is centrally involved in
the inflammatory response of human or murine macrophages to
these bacteria (28, 39). In agreement with those previous reports,
our studies using KO mice for TLR2, TLR4, TLR9, and MAL/
TIRAP revealed that TNF- and KC responses of AM to Brucella
infection were mainly mediated by TLR2 recognition; both re-
sponses were almost abolished in AM from TLR2 KO and MAL/
TIRAP KOmice. In addition, a slight but significant reduction of
TNF- and KC secretion was observed in AM from TLR9 KO
mice, and a slight diminution of TNF- was also observed in AM
from TLR4 KO mice. The participation of multiple TLRs in the
inflammatory response to Brucella infection or antigens agrees
with the published literature (8), although this study shows that
TLR2 recognition has a preponderant role in the case of AM. Al-
though not formally shown in the present study, it can be inferred
from the existing literature that the Brucella antigens involved in
the TLR2-mediated cytokine response of AMare outermembrane
lipoproteins (28).
Alveolar macrophages perform several protective functions in
the lung, including the phagocytosis and killing of invading
pathogens and the secretion of cytokines and chemokines that
contribute to the innate and adaptive immune response. In addi-
tion, like macrophages located in other tissues, AM process mi-
crobial antigens and display antigenic peptides in the context of
MHC molecules for their recognition by specific T cells. Gamma
interferon (IFN-) activates macrophages and induces their ex-
pression of MHC-II molecules, resulting in an enhanced antigen
presentation to specific CD4
 T cells and the consequent activa-
tion of the latter. This partially explains the central role of IFN- in
the protection against infections by intracellular pathogens.
Therefore, pathogens that can induce a downregulation of the
MHC-II expression induced by IFN- on macrophages may hin-
der the recognition of infected cells by specific T lymphocytes,
thus evading some adaptive immune responses. Interestingly,
Brucella has been reported to persist for a long time in the lungs of
infected mice (12), a phenomenon that can be speculated to be
due, at least in part, to the ability of the bacterium to evade the
immune recognition of infected AM. Of note, it has been previ-
ously shown that B. abortus infection can downregulate the IFN-
-induced expression of MHC-II molecules in human mono-
cytes, leading to a reduced antigen-specific T cell proliferation
(17). Against this background, we decided to evaluate whether
Brucella infection can also modulate MHC-II expression and an-
tigen presentation in AM. We found that infection of AM with B.
abortus reduced in an MOI-dependent manner the expression of
MHC-II molecules induced by IFN-. These findings agree not
only with our previous studies in humanmonocytes but also with
results from other groups showing that M. tuberculosis-infected
AM have decreased MHC class II molecule expression and de-
creased antigen presentation to specific CD4
 T cells (30).
Of note, it has been shown that the effects of Brucella on
MHC-II expression and antigen presentation mentioned above
do not require viable bacteria and can be similarly induced by
HKBA and also by L-Omp19, an outer membrane lipoprotein, in
both cases through TLR2-mediated recognition (17). Similarly, it
has been reported that viable M. tuberculosis is not required for
inhibition of macrophage MHC class II expression, which can be
achieved by exposure ofmacrophages toM. tuberculosis lysate and
also toM. tuberculosis lipoproteins, which are recognized by TLR2
(52). In line with those previous reports, we found that MHC-II
downregulation was induced in AM by incubation with HKBA or
L-Omp19, and that for both stimulants the effect wasmediated by
TLR2 recognition.Moreover, we found that the presence of either
L-Omp19 or HKBA during IFN- stimulation reduced signifi-
cantly the ability of AM to activate an MHC-II-restricted OVA-
specific T cell hybridoma. These results strongly suggest that AM
infected with Brucella remain undetected by specific T cells, en-
suring the long-term survival of such cells and, consequently, the
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long-termpersistence of the bacterium in the lung. The absence of
a significant cytotoxic effect of Brucella on AM may also contrib-
ute to the maintenance of these cells as a long-term reservoir of
bacteria.
The results obtained in the present study indicate that TLR2
recognition is involved both in the cytokine/chemokine response
of AM to Brucella infection and also in the downregulation of
MHC-II expression and antigen presentation induced by Brucella
and its antigens in AM. This dual effect of TLR2 recognition also
has been reported for the interaction of M. tuberculosis (or its
antigens) with macrophages. While activation of TLR2 by the 19-
kDa lipoprotein of M. tuberculosis induces the killing of intracel-
lular bacteria in both NO-dependent and -independent pathways
in murine macrophages and in human monocytes and alveolar
macrophages (53), prolonged TLR signaling byM. tuberculosis or
its 19-kDa lipoprotein has been shown to inhibit several IFN--
induced genes (54). It has been speculated that the latter mecha-
nism provides homeostatic feedback regulation to limit the extent
of the induced responses (37). In particular, it has been postulated
that the downregulation of antigen presentation is especially pro-
nounced during persistent infectionwith intravacuolar pathogens
that survive microbicidal mechanisms and that can persistently
colocalize with TLRs in phagosomes for prolonged TLR signaling
(37). LikeM. tuberculosis, Brucella can establish a prolonged resi-
dence in the phagosomes of tissue macrophages and can display
TLR2 agonists (like L-Omp19 and other lipoproteins), probably
allowing a chronic stimulation of TLR2 that may lead to the inhi-
bition of MHC-II expression and antigen presentation.
As mentioned, the TLR2-mediated recognition of Brucella an-
tigens induces the production of proinflammatory cytokines,
which may favor bacterial clearance, but also the downregulation
of MHC-II, which may favor bacterial persistence. The net effect
of TLR2 recognition on Brucella survival in AM probably results
from a balance between these two TLR2-mediated phenomena.
Notably, we detected viableB. abortus inAMofmice that had been
infected 1 week earlier through the intratracheal route, indicating
the ability of B. abortus to survive in vivo for a prolonged postin-
fection time within these cells. However, bacterial counts were
significantly higher in AM from TLR2 KO mice, indicating the
involvement of TLR2-mediated inflammation in the control of
lung infection by B. abortus. A previous study in intranasally in-
fected mice has shown that Brucella-infected AM migrate to the
draining lymph node, where they are detected as early as 1.5 days
postinfection (11). The fact that we detectedBrucella-infected AM
in the lungs at 1 week p.i. suggests that, upon infection, some
infected AMmigrate early to lymph nodes, whereas others remain
in the lung.
Collectively, these results suggest that B. abortus survives in
AM after inhalatory infection in spite of a certain degree of im-
mune control exerted by the TLR2-mediated inflammatory re-
sponse. Both themodest nature of the latter and themodulation of
MHC-II expression by the bacteriummay contribute to such sur-
vival. Further studies will be needed to determine whether AM
contribute to the reported persistence of brucellae in the lungs or
to a late dissemination of the bacterium from the lungs to distal
tissues.
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